Smart Drug Delivery Systems Market (Product: Connected Inhalers, Connected Autoinjectors, Connected Pen injectors, Connected Wearable Injectors, Add-on Sensors, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Sep 2022| TMR3317A| Transparency

Report Highlights

Smart Drug Delivery Systems Market – Scope of Report

TMR’s report on the global smart drug delivery systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global smart drug delivery systems market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global smart drug delivery systems market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the smart drug delivery systems market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global smart drug delivery systems market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global smart drug delivery systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global smart drug delivery systems market.

The report delves into the competitive landscape of the global smart drug delivery systems market. Key players operating in the global smart drug delivery systems market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global smart drug delivery systems market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market smart drug delivery systems.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

 

 

Frequently Asked Questions (FAQs)

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Smart Insulin Pen - Brand Analysis
  • Table 2 : Insulin Pen Delivery Devices Available in the United States
  • Table 3 : Global Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 4 : Global Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Drug Delivery Mode, 2017–2031
  • Table 5 : Global Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 6 : Global Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 7 : Global Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 8 : North America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 9 : North America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Drug Delivery Mode, 2017–2031
  • Table 10 : North America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 11 : North America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 12 : North America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 13 : Europe Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 14 : Europe Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Drug Delivery Mode, 2017–2031
  • Table 15 : Europe Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 16 : Europe Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 17 : Europe Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 18 : Asia Pacific Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 19 : Asia Pacific Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Drug Delivery Mode, 2017–2031
  • Table 20 : Asia Pacific Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 21 : Asia Pacific Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 22 : Asia Pacific Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 23 : Latin America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 24 : Latin America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Drug Delivery Mode, 2017–2031
  • Table 25 : Latin America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 26 : Latin America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 27 : Latin America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 28 : Middle East & Africa Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Product, 2017–2031
  • Table 29 : Middle East & Africa Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Drug Delivery Mode, 2017–2031
  • Table 30 : Middle East & Africa Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017–2031
  • Table 31 : Middle East & Africa Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
  • Table 32 : Middle East & Africa Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Figure 1 : Global Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 2 : Global Smart Drug Delivery Systems Market Analysis and Forecast, by Product, 2021 and 2031
  • Figure 3 : Global Smart Drug Delivery Systems Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 4 : Global Smart Drug Delivery Systems Market (US$ Mn), by Connected Inhalers, 2017–2031
  • Figure 5 : Global Smart Drug Delivery Systems Market (US$ Mn), by Connected Autoinjectors, 2017-2031
  • Figure 6 : Global Smart Drug Delivery Systems Market (US$ Mn), by Connected Pen Injectors, 2017-2031
  • Figure 7 : Global Smart Drug Delivery Systems Market (US$ Mn), by Connected Wearable Injectors, 2017-2031
  • Figure 8 : Global Smart Drug Delivery Systems Market (US$ Mn), by Add-on Sensors, 2017-2031
  • Figure 9 : Global Smart Drug Delivery Systems Market (US$ Mn), by Others, 2017-2031
  • Figure 10 : Global Smart Drug Delivery Systems Market Analysis and Forecast, by Drug Delivery Mode 2021 and 2031
  • Figure 11 : Global Smart Drug Delivery Systems Market Attractiveness Analysis, by Drug Delivery Mode, 2022–2031
  • Figure 12 : Global Smart Drug Delivery Systems Market (US$ Mn), by Injectable, 2017–2031
  • Figure 13 : Global Smart Drug Delivery Systems Market (US$ Mn), by Inhalation, 2017-2031
  • Figure 14 : Global Smart Drug Delivery Systems Market (US$ Mn), by Oral, 2017–2031
  • Figure 15 : Global Smart Drug Delivery Systems Market Analysis and Forecast, by Therapeutic Area, 2021 and 2031
  • Figure 16 : Global Smart Drug Delivery Systems Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 17 : Global Smart Drug Delivery Systems Market (US$ Mn), by Metabolic Disorders, 2017–2031
  • Figure 18 : Global Smart Drug Delivery Systems Market (US$ Mn), by Neurological Disorders, 2017-2031
  • Figure 19 : Global Smart Drug Delivery Systems Market (US$ Mn), by Respiratory Disorders, 2017-2031
  • Figure 20 : Global Smart Drug Delivery Systems Market (US$ Mn), by Hormonal Disorders, 2017-2031
  • Figure 21 : Global Smart Drug Delivery Systems Market Analysis and Forecast, by End-user, 2021 and 2031
  • Figure 22 : Global Smart Drug Delivery Systems Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 23 : Global Smart Drug Delivery Systems Market (US$ Mn), by Hospitals, 2017–2031
  • Figure 24 : Global Smart Drug Delivery Systems Market (US$ Mn), by Clinics, 2017-2031
  • Figure 25 : Global Smart Drug Delivery Systems Market (US$ Mn), by Home Care, 2017–2031
  • Figure 26 : Global Smart Drug Delivery Systems Market (US$ Mn), by Ambulatory Care Settings, 2017-2031
  • Figure 27 : Global Smart Drug Delivery Systems Market Analysis and Forecast, by Region, 2021 and 2031
  • Figure 28 : Global Smart Drug Delivery Systems Market Attractiveness Analysis, by Region, 2022–2031
  • Figure 29 : North America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 30 : North America Smart Drug Delivery Systems Market Analysis and Forecast, by Product, 2021 and 2031
  • Figure 31 : North America Smart Drug Delivery Systems Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 32 : North America Smart Drug Delivery Systems Market Analysis and Forecast, by Drug Delivery Mode, 2021 and 2031
  • Figure 33 : North America Smart Drug Delivery Systems Market Attractiveness Analysis, by Drug Delivery Mode, 2022–2031
  • Figure 34 : North America Smart Drug Delivery Systems Market Analysis and Forecast, by Therapeutic Area, 2021 and 2031
  • Figure 35 : North America Smart Drug Delivery Systems Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 36 : North America Smart Drug Delivery Systems Market Analysis and Forecast, by End-user, 2021 and 2031
  • Figure 37 : North America Smart Drug Delivery Systems Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 38 : North America Smart Drug Delivery Systems Market Analysis and Forecast, by Country, 2021 and 2031
  • Figure 39 : North America Smart Drug Delivery Systems Market Attractiveness Analysis, by Country, 2022–2031
  • Figure 40 : Europe Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 41 : Europe Smart Drug Delivery Systems Market Analysis and Forecast, by Product, 2021 and 2031
  • Figure 42 : Europe Smart Drug Delivery Systems Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 43 : Europe Smart Drug Delivery Systems Market Analysis and Forecast, by Drug Delivery Mode. 2021 and 2031
  • Figure 44 : Europe Smart Drug Delivery Systems Market Attractiveness Analysis, by Drug Delivery Mode, 2022–2031
  • Figure 45 : Europe Smart Drug Delivery Systems Market Analysis and Forecast, by Therapeutic Area, 2021 and 2031
  • Figure 46 : Europe Smart Drug Delivery Systems Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 47 : Europe Smart Drug Delivery Systems Market Analysis and Forecast, by End-user, 2021 and 2031
  • Figure 48 : Europe Smart Drug Delivery Systems Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 49 : Europe Smart Drug Delivery Systems Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
  • Figure 50 : Europe Smart Drug Delivery Systems Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 51 : Asia Pacific Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 52 : Asia Pacific Smart Drug Delivery Systems Market Analysis and Forecast, by Product, 2021 and 2031
  • Figure 53 : Asia Pacific Smart Drug Delivery Systems Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 54 : Asia Pacific Smart Drug Delivery Systems Market Analysis and Forecast, by Drug Delivery Mode 2021 and 2031
  • Figure 55 : Asia Pacific Smart Drug Delivery Systems Market Attractiveness Analysis, by Drug Delivery Mode, 2022–2031
  • Figure 56 : Asia Pacific Smart Drug Delivery Systems Market Analysis and Forecast, by Therapeutic Area, 2021 and 2031
  • Figure 57 : Asia Pacific Smart Drug Delivery Systems Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 58 : Asia Pacific Smart Drug Delivery Systems Market Analysis and Forecast, by End-user, 2021 and 2031
  • Figure 59 : Asia Pacific Smart Drug Delivery Systems Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 60 : Asia Pacific Smart Drug Delivery Systems Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
  • Figure 61 : Asia Pacific Smart Drug Delivery Systems Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 62 : Latin America Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 63 : Latin America Smart Drug Delivery Systems Market Analysis and Forecast, by Product, 2021 and 2031
  • Figure 64 : Latin America Smart Drug Delivery Systems Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 65 : Latin America Smart Drug Delivery Systems Market Analysis and Forecast, by Drug Delivery Mode, 2021 and 2031
  • Figure 66 : Latin America Smart Drug Delivery Systems Market Attractiveness Analysis, by Drug Delivery Mode, 2022–2031
  • Figure 67 : Latin America Smart Drug Delivery Systems Market Analysis and Forecast, by Therapeutic Area, 2021 and 2031
  • Figure 68 : Latin America Smart Drug Delivery Systems Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 69 : Latin America Smart Drug Delivery Systems Market Analysis and Forecast, by End-user, 2021 and 2031
  • Figure 70 : Latin America Smart Drug Delivery Systems Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 71 : Latin America Smart Drug Delivery Systems Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
  • Figure 72 : Latin America Smart Drug Delivery Systems Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 73 : Middle East & Africa Smart Drug Delivery Systems Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 74 : Middle East & Africa Smart Drug Delivery Systems Market Analysis and Forecast, by Product, 2021 and 2031
  • Figure 75 : Middle East & Africa Smart Drug Delivery Systems Market Attractiveness Analysis, by Product, 2022–2031
  • Figure 76 : Middle East & Africa Smart Drug Delivery Systems Market Analysis and Forecast, by Drug Delivery Mode, 2021 and 2031
  • Figure 77 : Middle East & Africa Smart Drug Delivery Systems Market Attractiveness Analysis, by Drug Delivery Mode, 2022–2031
  • Figure 78 : Middle East & Africa Smart Drug Delivery Systems Market Analysis and Forecast, by Therapeutic Area, 2021 and 2031
  • Figure 79 : Middle East & Africa Smart Drug Delivery Systems Market Attractiveness Analysis, by Therapeutic Area, 2022–2031
  • Figure 80 : Middle East & Africa Smart Drug Delivery Systems Market Analysis and Forecast, by End-user, 2021 and 2031
  • Figure 81 : Middle East & Africa Smart Drug Delivery Systems Market Attractiveness Analysis, by End-user, 2022–2031
  • Figure 82 : Middle East & Africa Smart Drug Delivery Systems Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
  • Figure 83 : Middle East & Africa Smart Drug Delivery Systems Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 84 : Global Smart Drug Delivery Systems Market Share Analysis/Ranking, by Company, 2021

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Transparency
Price: $5795

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS